Sort by:
77 products
77 products
GLIOZAC
Comparable to: N/A
Active ingredient: PIOGLITAZONE
Concentration: 15MG
Presentation: 7 TABLETS
Laboratory: MAVER
Origin: Made in Mexico
Pioglitazone is an oral antidiabetic from the thiazolidinedione group, used to improve glycemic control in patients with type 2 diabetes mellitus. It works by improving insulin sensitivity in muscle, adipose, and hepatic tissues. It helps to reduce insulin resistance, lowering glucose levels.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before taking any medication.
GLIOZAC
Comparable to: N/A
Active ingredient: PIOGLITAZONE
Concentration: 30MG
Presentation: 7 TABLETS
Laboratory: MAVER
Origin: Made in Mexico
Pioglitazone is an oral antidiabetic from the thiazolidinedione group, used to improve glycemic control in patients with type 2 diabetes mellitus. It works by improving insulin sensitivity in muscle, adipose, and liver tissues. It helps reduce insulin resistance, lowering glucose levels.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
Glunovag (Metformin) 850 mg
Comparable to: N/A
Active ingredient: Metformin
Concentration: 850 mg per tablet
Presentation: Bottle with 30 tablets
Laboratory: NOVAG
Origin: Made in Mexico
This generic medication is an oral antidiabetic drug used for the treatment of type 2 diabetes mellitus. It primarily works by reducing glucose production in the liver and improving the body's cells' sensitivity to insulin. It helps control blood sugar levels and may promote weight loss in some patients.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
INCRESINA (ALOGLIPTIN) 25MG 14 TABS
Comparable to: NESINA
Active ingredient: ALOGLIPTIN
Concentration: 25MG
Presentation: 14 TABS
Laboratory: TAKEDA
Origin: Made in Mexico
Alogliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type 2 diabetes. It increases active incretin hormone levels, resulting in improved glycemic control by regulating insulin and glucagon production. It helps reduce post-prandial blood sugar.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
Insogen Plus (Metformin / Chlorpropamide)
Comparable to: N/A
Active ingredient: Metformin / Chlorpropamide
Concentration: As directed by physician
Presentation: Box with 40 tablets
Laboratory: ITALMEX
Origin: Made in Mexico
This brand-name medication is a combination used for the control of type 2 diabetes mellitus. Metformin reduces hepatic glucose production and improves insulin sensitivity, while Chlorpropamide stimulates insulin release from the pancreas. Together, they effectively help lower blood glucose levels.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
INSUSYM (GLIBENCLAMIDE) 5MG 100 TABLETS
Comparable to: N/A
Active ingredient: Glibenclamide
Concentration: 5 mg per tablet
Presentation: Box with 100 tablets
Laboratory: Insusym
Origin: Made in Mexico
This medication belongs to the sulfonylurea group and is used to control blood glucose levels in patients with type 2 diabetes mellitus. It works by stimulating the release of insulin from the pancreas, helping to maintain blood glucose within healthy ranges and preventing long-term complications of diabetes.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
JANUMET (SITAGLIPTIN / METFORMIN)
Comparable to: Janumet
Active ingredient: Sitagliptin / Metformin
Concentration: 50 mg / 1000 mg per tablet
Presentation: Box with 56 tablets
Laboratory: Merck
Origin: Mexico
Janumet is a medication used for the treatment of type 2 diabetes mellitus when diet and exercise alone are not sufficient to control blood glucose levels. Sitagliptin helps increase incretin levels, improving insulin release and reducing glucose production, while metformin improves insulin sensitivity and decreases glucose production in the liver.
The consumption of this product is the responsibility of whoever recommends and whoever uses it. Consult your doctor before consuming any medication.
JANUMET (SITAGLIPTIN / METFORMIN)
Comparable to: Janumet
Active ingredient: Sitagliptin / Metformin
Concentration: 50 mg / 500 mg per tablet
Presentation: Box with 56 tablets
Laboratory: Merck
Origin: Mexico
Janumet is a medication used for the treatment of type 2 diabetes mellitus when diet and exercise alone are not sufficient to control blood glucose levels. Sitagliptin works by increasing incretin levels, which improves insulin release and reduces glucose production, while metformin improves insulin sensitivity and decreases hepatic glucose production.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
JANUMET
Comparable to: N/A
Active ingredient: SITAGLIPTIN/METFORMIN
Concentration: 50/850MG
Presentation: 28 TABLETS
Laboratory: MERCK
Origin: Made in Mexico
This medication combines Sitagliptin and Metformin for the treatment of type 2 diabetes. Sitagliptin improves glycemic control by increasing incretin hormone levels, while Metformin reduces hepatic glucose production and improves insulin sensitivity. They work together for effective blood sugar control.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
JANUMET XR
Comparable to: N/A
Active ingredient: Sitagliptin/metformin
Strength: 50/1000
Presentation: 56 TABS
Laboratory: MERCK
Origin: Made in Mexico
This medication combines Sitagliptin and Metformin for the treatment of type 2 diabetes. Sitagliptin improves glycemic control by increasing incretin hormone levels, while Metformin reduces hepatic glucose production and improves insulin sensitivity. They work together for effective blood sugar control.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
JANUVIA
Comparable to: N/A
Active ingredient: SITAGLIPTIN
Concentration: 100MG
Presentation: 28 TABLETS
Laboratory: MERCK
Origin: Made in Mexico
Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used in the treatment of type 2 diabetes mellitus. It works by increasing levels of incretin hormones, which results in increased insulin release and decreased glucagon production. It helps to effectively control blood glucose levels.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before taking any medication.
JANUVIA
Comparable to: N/A
Active ingredient: SITAGLIPTIN
Concentration: 50MG
Presentation: 28 TABLETS
Laboratory: MERCK
Origin: Made in Mexico
Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used in the treatment of type 2 diabetes mellitus. It works by increasing levels of incretin hormones, resulting in increased insulin release and decreased glucagon production. It helps to effectively control blood glucose levels.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
JARDIANZ
Comparable to: JARDIANCE
Active ingredient: Empagliflozin
Concentration: 10MG
Presentation: 30 TABLETS
Laboratory: Boehringer Ingelheim
Origin: Made in Mexico
Sodium-glucose cotransporter 2 (SGLT2) inhibitor used for the treatment of type 2 diabetes. It works by blocking glucose reabsorption in the kidneys, promoting its elimination through urine and reducing blood glucose levels. Additionally, it offers cardiovascular and renal benefits.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before taking any medication.
JARDIANZ
Comparable to: N/A
Active ingredient: EMPAGLIFLOZIN
Concentration: 25MG
Presentation: 10 TAB
Laboratory: BOEHRINGER INGELHEIM
Origin: Made in Mexico
Empagliflozin is an SGLT2 inhibitor used for type 2 diabetes. It works by blocking glucose reabsorption in the kidneys, leading to glucose excretion through urine. It helps reduce blood glucose levels, body weight, and blood pressure.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.

{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>